N
Nextage Therapeutics Ltd
TASE:NXTG
Nextage Therapeutics Ltd
TASE:NXTG
Price:
64.1
ILS
-17.72%
Market Cap:
₪48.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nextage Therapeutics Ltd
TASE:NXTG
|
IL |
|
Clearway Energy Inc
NYSE:CWEN.A
|
US |
Income Statement
Earnings Waterfall
Nextage Therapeutics Ltd
Nextage Therapeutics Ltd
Income Statement
Nextage Therapeutics Ltd
Nextage Therapeutics Ltd
Currency: ILS
| Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
+13%
|
0
-43%
|
0
-13%
|
0
-45%
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+437%
|
1
+17%
|
0
-60%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
+20%
|
0
-85%
|
0
-86%
|
0
+220%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+477%
|
0
+3%
|
0
-67%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(5)
|
(4)
|
(6)
|
(17)
|
(7)
|
(10)
|
(6)
|
(5)
|
(4)
|
(4)
|
(4)
|
|
| Selling, General & Administrative |
(4)
|
(3)
|
(6)
|
(6)
|
(5)
|
(7)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
|
| Research & Development |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(4)
N/A
|
(3)
+26%
|
(6)
-96%
|
(17)
-169%
|
(7)
+59%
|
(10)
-42%
|
(6)
+42%
|
(5)
+12%
|
(4)
+22%
|
(4)
+11%
|
(3)
+3%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
2
|
2
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
(9)
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(2)
N/A
|
(1)
+63%
|
(16)
-1 963%
|
(17)
-8%
|
(8)
+54%
|
(11)
-38%
|
(6)
+45%
|
(5)
+9%
|
(4)
+23%
|
(4)
+15%
|
(3)
+3%
|
|
| Net Income | ||||||||||||
| Income from Continuing Operations |
(2)
|
(1)
|
(16)
|
(17)
|
(8)
|
(11)
|
(6)
|
(5)
|
(4)
|
(4)
|
(3)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(2)
N/A
|
(1)
+63%
|
(16)
-1 963%
|
(17)
-7%
|
(8)
+53%
|
(11)
-33%
|
(6)
+48%
|
(5)
+8%
|
(4)
+25%
|
(3)
+13%
|
(3)
+2%
|
|
| EPS (Diluted) |
-1.14
N/A
|
-0.34
+70%
|
-1.4
-312%
|
-0.65
+54%
|
-0.31
+52%
|
-0.41
-32%
|
-0.2
+51%
|
-0.18
+10%
|
-0.13
+28%
|
-0.11
+15%
|
-0.1
+9%
|
|
Switch to:
Switch to:
See Also
Discover More
